{"id":"W1976072188","doi":"10.1007/s00345-004-0477-x","title":"Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer","year":2005,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Tolerability; Docetaxel; Internal medicine; Cancer; Clinical trial; Chemotherapy; Cancer research; Prostate; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003584642,0.0004785706,0.0009979835,0.0006091938,0.0001823988,0.0004110774,0.0005888099,0.0005121946,0.00127065],"category_scores_gemma":[0.0003189593,0.0001301168,0.0003193503,0.0006027765,0.00028422,0.0004539125,0.0002863377,0.001024224,0.0007498487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004111804,"about_ca_system_score_gemma":0.0004404494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004539577,"about_ca_topic_score_gemma":0.001540233,"domain_scores_codex":[0.999915,0.00001724395,0.00001022183,0.00001199577,0.00003264876,0.00001284006],"domain_scores_gemma":[0.999909,0.00004232084,0.00001826087,0.000003307741,0.00001728442,0.000009818447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003067493,0.00008558181,0.0002572215,0.003329598,0.00008643725,0.0004551315,0.00003002589,0.0004099759,0.003006106,0.001003708,0.013602,0.9774274],"study_design_scores_gemma":[0.0004948145,0.0009385202,0.002925395,0.001047752,0.0002871952,0.006689287,0.00006166478,0.0005158286,0.005176394,0.00146392,0.9803671,0.00003210319],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002060553,0.9945468,0.0006896651,0.000634524,0.0004064,0.00001339197,0.0000209809,0.00002600295,0.001601744],"genre_scores_gemma":[0.01688071,0.977692,0.0008474611,0.0007356026,0.0004203703,0.00002919991,0.00007281272,0.000006021704,0.003315795],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00127065,"threshold_uncertainty_score":0.004250765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01033542034409385,"score_gpt":0.2694842767734028,"score_spread":0.259148856429309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}